Cognex (NASDAQ:CGNX) Price Target Raised to $85.00

Cognex (NASDAQ:CGNX) had its target price hoisted by Barclays from $80.00 to $85.00 in a research report released on Monday,Benzinga reports. They currently have an overweight rating on the scientific and technical instruments company’s stock.

Several other equities research analysts have also recently weighed in on CGNX. Zacks Research cut shares of Cognex from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $91.00 price objective on shares of Cognex in a research report on Friday, August 7th. Wall Street Zen lowered Cognex from a “buy” rating to a “hold” rating in a research note on Sunday, September 13th. Cantor Fitzgerald lifted their target price on Cognex from $76.00 to $84.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. Finally, HSBC downgraded shares of Cognex from a “buy” rating to a “hold” rating and set a $65.00 target price for the company. in a report on Monday, August 10th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, Cognex presently has an average rating of “Moderate Buy” and an average target price of $75.57.

Cognex Price Performance

NASDAQ:CGNX opened at $57.27 on Monday. Cognex has a 1-year low of $34.60 and a 1-year high of $72.88. The company has a 50-day moving average of $61.57 and a 200 day moving average of $61.55. The firm has a market cap of $9.63 billion, a PE ratio of 49.19 and a beta of 1.48.

Cognex (NASDAQ:CGNX) last posted its earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.42 by $0.03. Cognex had a net margin of 16.05% and a return on equity of 13.50%. The business had revenue of $291.26 million for the quarter, compared to the consensus estimate of $292.10 million. During the same quarter last year, the firm posted $0.25 EPS. The company’s revenue for the quarter was up 16.9% on a year-over-year basis. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. Sell-side analysts anticipate that Cognex will post 1.68 EPS for the current fiscal year.

Cognex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 3rd. Stockholders of record on Thursday, August 20th were issued a dividend of $0.0850 per share. This represents a $0.34 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Thursday, August 20th. Cognex’s dividend payout ratio is currently 33.01%.

Institutional Trading of Cognex

Institutional investors have recently made changes to their positions in the business. IFP Advisors Inc increased its position in Cognex by 21.6% during the 2nd quarter. IFP Advisors Inc now owns 956 shares of the scientific and technical instruments company’s stock valued at $69,000 after buying an additional 170 shares in the last quarter. State of Michigan Retirement System increased its stake in Cognex by 0.5% during the 1st quarter. State of Michigan Retirement System now owns 39,853 shares of the scientific and technical instruments company’s stock valued at $1,952,000 after purchasing an additional 200 shares in the last quarter. Mather Group LLC. lifted its stake in shares of Cognex by 81.3% during the third quarter. Mather Group LLC. now owns 446 shares of the scientific and technical instruments company’s stock worth $27,000 after buying an additional 200 shares during the period. Eastern Bank lifted its stake in shares of Cognex by 20.0% during the third quarter. Eastern Bank now owns 1,242 shares of the scientific and technical instruments company’s stock worth $75,000 after buying an additional 207 shares during the period. Finally, Personal CFO Solutions LLC grew its holdings in shares of Cognex by 3.2% during the first quarter. Personal CFO Solutions LLC now owns 6,793 shares of the scientific and technical instruments company’s stock valued at $333,000 after buying an additional 212 shares during the last quarter. Institutional investors and hedge funds own 88.12% of the company’s stock.

About Cognex

Cognex Corporation (NASDAQ: CGNX) develops machine vision products and technologies that help businesses automate manufacturing, logistics and other industrial processes. Its systems enable machines to inspect, identify, measure and guide products, components and materials with limited human intervention.

The company’s product portfolio includes industrial vision cameras, vision sensors, image-based barcode readers, three-dimensional vision systems and software for image processing and analysis.